Nikolakopoulou, A., Tzimopoulos, K., Kerasiotis, H., Kallianos, A., Kavvada, C., Gkartzonika, H., . . . Rapti, A. (2016). AB018. Evaluation of nivolumab as second-line treatment in patients with advanced non-small cell lung cancer (NSCLC). Ann Transl Med.
Stile di citazione ChicagoNikolakopoulou, Asimina, Kon/nos Tzimopoulos, Haralambos Kerasiotis, Anastasios Kallianos, Catherine Kavvada, Helen Gkartzonika, Emilia Tsarouha, e Angeliki Rapti. "AB018. Evaluation of Nivolumab As Second-line Treatment in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)." Ann Transl Med 2016.
Citazione MLANikolakopoulou, Asimina, et al. "AB018. Evaluation of Nivolumab As Second-line Treatment in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)." Ann Transl Med 2016.